Evidence map›Paper›PMID 27068063›Full record

ArticleFree radical biology & medicine2016

Activation of Wnt/β-catenin signaling by hydrogen peroxide transcriptionally inhibits NaV1.5 expression.

Ning Wang, Rong Huo, Benzhi Cai, Yan Lu, Bo Ye, Xiang Li, Faqian Li, Haodong Xu

Open access · greenAbstract read
In one paragraph

Article in Free radical biology & medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases.International journal of molecular sciences · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. A small-molecule LF3 abrogates β-catenin/TCF4-mediated suppression of NaJournal of molecular and cellular cardiology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ning WangDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, 10833 Le Conte Ave., CHS 13-145E, Los Angeles, CA 90095-1732, USA.
Rong HuoDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, 10833 Le Conte Ave., CHS 13-145E, Los Angeles, CA 90095-1732, USA.
Benzhi CaiDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Yan LuDivision of Cardiology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Bo YeDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Xiang LiDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Faqian LiDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Haodong XuDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, 10833 Le Conte Ave., CHS 13-145E, Los Angeles, CA 90095-1732, USA; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: HaodongXu@mednet.ucla.edu.
University of Rochester Medical Center · USUniversity of California, Los Angeles · US

Funding

WNT/BETACANTENIN SIGNALING AND CARDIAC ION CHANNELSR01HL122793 · NHLBI · UNIVERSITY OF WASHINGTON · PI XU, HAODONG · 2015 to 2019
$2.0M
Nuclear beta-catenin signaling in the heartR01HL111480 · NHLBI · UNIVERSITY OF ROCHESTER · PI LI, FAQIAN · 2012 to 2016
$1.9M
NHLBI NIH HHS R01 HL111480NHLBI NIH HHS R01 HL122793
6 · The paper itself

Abstract

Oxidants and canonical Wnt/β-catenin signaling have been shown to decrease cardiac Na(+) channel activity by suppressing NaV1.5 expression. Our aims are to determine if hydrogen peroxide (H2O2), one oxidant of reactive oxygen species (ROS), activates Wnt/β-catenin signaling and promotes β-catenin nuclear activity, leading to suppression of NaV1.5 expression and if this suppression requires the interaction of β-catenin with its nuclear partner, TCF4 (also called TCF7L2) to decrease SCN5a promoter activity. The results demonstrated that H2O2 increased β-catenin, but not TCF4 nuclear localization determined by immunofluorescence without affecting total β-catenin protein level. Furthermore, H2O2 exerted a dose- and time-dependent suppressive effect on NaV1.5 expression. RT-PCR and/or Western blot analyses revealed that overexpressing active form of β-catenin or stabilizing β-catenin by GSK-3β inhibitors, LiCl and Bio, suppressed NaV1.5 expression in HL-1 cells. In contrast, destabilization of β-catenin by a constitutively active GSK-3β mutant (S9A) upregulated NaV1.5 expression. Whole-cell recording showed that LiCl significantly inhibited Na(+) channel activity in these cells. Using immunoprecipitation (IP), we showed that β-catenin interacted with TCF4 indicating that β-catenin as a co-transfactor, regulates NaV1.5 expression through TCF4. Analyses of the SCN5a promoter sequences among different species by using VISTA tools indicated that SCN5a promoter harbors TCF4 binding sites. Chromatin IP assays demonstrated that both β-catenin and TCF4 were recruited in the SCN5a promoter, and regulated its activity. Luciferase promoter assays exhibited that β-catenin inhibited the SCN5a promoter activity at a dose-dependent manner and this inhibition required TCF4. Small interfering (Si) RNA targeting β-catenin significantly increased SCN5a promoter activity, leading to enhanced NaV1.5 expression. As expected, β-catenin SiRNA prevents H2O2 suppressive effects on both SCN5a promoter activity and NaV1.5 expression. Our findings indicate that H2O2 inhibits NaV1.5 expression by activating the Wnt/β-catenin signaling and β-catenin interacts with TCF4 to transcriptionally suppress cardiac NaV1.5 expression.

Indexed as

Animalsbeta CateninBinding SitesCell LineChromatin ImmunoprecipitationGene Expression RegulationGlycogen Synthase Kinase 3 betaHumansHydrogen PeroxideLithium ChlorideMiceMutationMyocytes, CardiacNAV1.5 Voltage-Gated Sodium ChannelPatch-Clamp TechniquesPromoter Regions, Geneticbeta CateninCTNNB1 protein, mouseGlycogen Synthase Kinase 3 betaHydrogen PeroxideLithium ChlorideNAV1.5 Voltage-Gated Sodium ChannelReactive Oxygen SpeciesRNA, Small InterferingScn5a protein, mouseTcf4 protein, mouseTranscription Factor 4Hydrogen peroxideNa(V)1.5OxidantSCN5a promoterTCF4β-Catenin

Identifiers

PMID27068063
PMCPMC4912406
OpenAlexW2316302203

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.